NCT00000719View on ClinicalTrials.gov

A Trial of Alternating 2',3'-Dideoxycytidine and Zidovudine in the Treatment of Patients With Advanced HIV Disease

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

Not specified

Study Completion Date

February 28, 1995

Conditions

HIV Infections

Interventions

DRUG

Zidovudine

DRUG

Zalcitabine

Trial Locations (7)

33136

Univ. of Miami AIDS CRS, Miami

55455

University of Minnesota, ACTU, Minneapolis

60611

Northwestern University CRS, Chicago

70112

Tulane Med. Ctr. - Charity Hosp. of New Orleans, ACTU, New Orleans

90033

USC CRS, Los Angeles

92103

Ucsd, Avrc Crs, San Diego

Unknown

Rush Univ. Med. Ctr. ACTG CRS, Chicago

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00000719 - A Trial of Alternating 2',3'-Dideoxycytidine and Zidovudine in the Treatment of Patients With Advanced HIV Disease | Biotech Hunter | Biotech Hunter